AAAAAA
Results: 1-25/26
Authors:
KASPER S
TAUSCHER J
KUFFERLE B
BARNAS C
HESSELMANN B
ASENBAUM S
PODREKA I
BRUCKE T
Citation: S. Kasper et al., SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY, Psychopharmacology, 136(4), 1998, pp. 367-373
Authors:
KASPER S
TAUSCHER J
KUFFERLE B
HESSELMANN B
BARNAS C
BRUCKE T
Citation: S. Kasper et al., IBZM-SPECT IMAGING OF DOPAMINE D-2 RECEPTORS WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS, European psychiatry, 13, 1998, pp. 9-14
Authors:
KAPITANY T
MESZAROS K
LENZINGER E
SCHINDLER SD
BARNAS C
FUCHS K
SIEGHART W
ASCHAUER HN
KASPER S
Citation: T. Kapitany et al., GENETIC POLYMORPHISMS FOR DRUG-METABOLISM (CYP2D6) AND TARDIVE-DYSKINESIA IN SCHIZOPHRENIA, Schizophrenia research, 32(2), 1998, pp. 101-106
Authors:
WILLEIT M
BARNAS C
TAUSCHER J
KUFFERLE B
KRENN P
ASENBAUM S
BRUCKE T
KASPER S
Citation: M. Willeit et al., VISUALIZATION OF DOPAMINE-2 RECEPTOR BLOCKADE IN PSYCHOTIC-PATIENTS TREATED WITH ZOTEPINE, Schizophrenia research, 29(1-2), 1998, pp. 204-204
Authors:
GRATAS C
TOHMA Y
BARNAS C
TANIERE P
HAINAUT P
OHGAKI H
Citation: C. Gratas et al., UP-REGULATION OF FAS (APO-1 CD95) LIGAND AND DOWN-REGULATION OF FAS EXPRESSION IN HUMAN ESOPHAGEAL CANCER/, Cancer research, 58(10), 1998, pp. 2057-2062
Authors:
KASPER S
BARNAS C
HEIDEN A
VOLZ HP
LAAKMANN G
ZEIT H
PFOLZ H
Citation: S. Kasper et al., PRAMIPEXOLE AS ADJUNCT TO HALOPERIDOL IN SCHIZOPHRENIA SAFETY AND EFFICACY, European neuropsychopharmacology, 7(1), 1997, pp. 65-70
Authors:
PRASCHAKRIEDER N
NEUMEISTER A
HESSELMANN B
WILLEIT M
BARNAS C
KASPER S
Citation: N. Praschakrieder et al., SUICIDAL TENDENCIES AS A COMPLICATION OF LIGHT THERAPY FOR SEASONAL AFFECTIVE-DISORDER - A REPORT OF 3 CASES, The Journal of clinical psychiatry, 58(9), 1997, pp. 389-392
Authors:
BARNAS C
MARTELPLANCHE G
FURUKAWA Y
HOLLSTEIN M
MONTESANO R
HAINAUT P
Citation: C. Barnas et al., INACTIVATION OF THE P53 PROTEIN IN CELL-LINES DERIVED FROM HUMAN ESOPHAGEAL CANCERS, International journal of cancer, 71(1), 1997, pp. 79-87
Authors:
TAUSCHER J
KUFFERLE B
BARNAS C
ASENBAUM S
BRUCKE T
KASPER S
Citation: J. Tauscher et al., D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, CLOZAPINE, RISPERIDONE AND HALOPERIDOL, Biological psychiatry, 41, 1997, pp. 39-39
Authors:
TAUSCHER J
KUFFERLE B
BARNAS C
ASENBAUM S
BRUCKE T
KASPER S
Citation: J. Tauscher et al., PREMEDICATION INFLUENCED D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE AND SERTINDOLE, Biological psychiatry, 41, 1997, pp. 40-40
Authors:
KASPER S
KUFFERLE B
TAUSCHER J
ASENBAUM S
BARNAS C
HESSELMANN B
PODREKA I
BRUCKE T
Citation: S. Kasper et al., DOPAMINE D-2 RECEPTOR-BINDING IN TYPICAL AND ATYPICAL NEUROLEPTICS, Biological psychiatry, 41, 1997, pp. 227-227
Authors:
ELLMEIER W
BARNAS C
KOBRNA A
KLEINER E
KURZBAUER R
WEITH A
Citation: W. Ellmeier et al., CLONING AND CHARACTERIZATION OF CPG ISLANDS OF THE HUMAN-CHROMOSOME 1P36 REGION, Genomics, 32(1), 1996, pp. 155-158
Authors:
KASPER S
TAUSCHER J
KUFFERLE B
HEIDEN A
NEUMEISTER A
BARNAS C
ASENBAUM S
PODREKA I
BRUCKE T
Citation: S. Kasper et al., D2 - RECEPTOR IMAGING (SPECT) AS A TOOL FOR MEASURING THE EFFICACY AND SIDE-EFFECT PROFILE OF TREATMENT WITH NEUROLEPTICS, Biological psychiatry, 39(7), 1996, pp. 224-224
Authors:
KAPITANY T
HESSELMANN B
SCHINDLER SD
BARNAS C
SIEGHART W
KASPER S
Citation: T. Kapitany et al., NEUROENDOCRINE RESPONSES TO THE CITALOPRAM CHALLENGE TEST IN DEPRESSION, Biological psychiatry, 39(7), 1996, pp. 501-501
Authors:
SCHINDLER SD
KAPITANY T
HELLELMANN B
BARNAS C
SIEGHART W
KASPER S
Citation: Sd. Schindler et al., BLUNTED NEUROENDOCRINE RESPONSE TO CITALOPRAM CHALLENGE IN DIABETES (TYPE-1), Biological psychiatry, 39(7), 1996, pp. 502-502
Authors:
MILLER CH
SIMIONI I
OBERBAUER H
SCHWITZER J
BARNAS C
KULHANEK F
BOISSEL KE
MEISE U
HINTERHUBER H
FLEISCHHACKER WW
Citation: Ch. Miller et al., TARDIVE-DYSKINESIA PREVALENCE RATES DURING A 10-YEAR FOLLOW-UP, The Journal of nervous and mental disease, 183(6), 1995, pp. 404-407
Authors:
SCHINDLER S
BARNAS C
LEITNER H
KAPITANY T
KASPER S
Citation: S. Schindler et al., TRIGEMINAL NEURALGIC SYNDROME AFTER BRIGHT LIGHT THERAPY, The American journal of psychiatry, 152(8), 1995, pp. 1237-1237
Authors:
STUPPAECK CH
BARNAS C
FALK M
GUENTHER V
HUMMER M
OBERBAUER H
PYCHA R
WHITWORTH AB
FLEISCHHACKER WW
Citation: Ch. Stuppaeck et al., ASSESSMENT OF THE ALCOHOL-WITHDRAWAL SYNDROME - VALIDITY AND RELIABILITY OF THE TRANSLATED AND MODIFIED CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCALE (CIWA-A), Addiction, 89(10), 1994, pp. 1287-1292
Authors:
STUPPAECK CH
BARNAS C
SCHWITZER J
FLEISCHHACKER WW
Citation: Ch. Stuppaeck et al., CARBAMAZEPINE IN THE PROPHYLAXIS OF MAJOR DEPRESSION - A 5-YEAR FOLLOW-UP, The Journal of clinical psychiatry, 55(4), 1994, pp. 146-150
Authors:
HUMMER M
KURZ M
BARNAS C
SARIA A
FLEISCHHACKER WW
Citation: M. Hummer et al., CLOZAPINE-INDUCED TRANSIENT WHITE BLOOD-COUNT DISORDERS, The Journal of clinical psychiatry, 55(10), 1994, pp. 429-432
Authors:
BARNAS C
BERGANT A
HUMMER M
SARIA A
FLEISCHHACKER WW
Citation: C. Barnas et al., CLOZAPINE CONCENTRATIONS IN MATERNAL AND FETAL PLASMA, AMNIOTIC-FLUID, AND BREAST-MILK, The American journal of psychiatry, 151(6), 1994, pp. 945-945
Authors:
BARNAS C
WHITWORTH AB
FLEISCHHACKER WW
Citation: C. Barnas et al., ARE PATTERNS OF BENZODIAZEPINE USE PREDICTABLE - A FOLLOW-UP-STUDY OFBENZODIAZEPINE USERS, Psychopharmacology, 111(3), 1993, pp. 301-305
Authors:
STUPPAECK C
BARNAS C
SCHWITZER J
FLEISCHHACKER WW
Citation: C. Stuppaeck et al., THE ROLE OF CARBAMAZEPINE IN THE PROPHYLAXIS OF UNIPOLAR DEPRESSION, Neuropsychobiology, 27(3), 1993, pp. 154-157
Authors:
PYCHA R
MILLER C
BARNAS C
HUMMER M
STUPPACK C
WHITWORTH A
FLEISCHHACKER WW
Citation: R. Pycha et al., INTRAVENOUS FLUNITRAZEPAM IN THE TREATMENT OF ALCOHOL-WITHDRAWAL DELIRIUM, Alcoholism, clinical and experimental research, 17(4), 1993, pp. 753-757
Authors:
FLEISCHHACKER WW
MILLER CH
BARNAS C
BERGMANN K
PEROVICH R
ALVIR JMJ
LIEBERMAN JA
KANE JM
Citation: Ww. Fleischhacker et al., THE EFFECT OF ACTIVATION PROCEDURES ON NEUROLEPTIC-INDUCED AKATHISIA, British Journal of Psychiatry, 163, 1993, pp. 781-784